These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 21953456)

  • 1. Mechanism of HIV reverse transcriptase inhibition by zinc: formation of a highly stable enzyme-(primer-template) complex with profoundly diminished catalytic activity.
    Fenstermacher KJ; DeStefano JJ
    J Biol Chem; 2011 Nov; 286(47):40433-42. PubMed ID: 21953456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apparent defects in processive DNA synthesis, strand transfer, and primer elongation of Met-184 mutants of HIV-1 reverse transcriptase derive solely from a dNTP utilization defect.
    Gao L; Hanson MN; Balakrishnan M; Boyer PL; Roques BP; Hughes SH; Kim B; Bambara RA
    J Biol Chem; 2008 Apr; 283(14):9196-205. PubMed ID: 18218634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 reverse transcriptase-catalyzed DNA strand transfer reactions by 4-chlorophenylhydrazone of mesoxalic acid.
    Davis WR; Tomsho J; Nikam S; Cook EM; Somand D; Peliska JA
    Biochemistry; 2000 Nov; 39(46):14279-91. PubMed ID: 11087377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-nucleoside Reverse Transcriptase Inhibitors Inhibit Reverse Transcriptase through a Mutually Exclusive Interaction with Divalent Cation-dNTP Complexes.
    DeStefano JJ
    Biochemistry; 2019 Apr; 58(16):2176-2187. PubMed ID: 30900874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A polymorphism at position 400 in the connection subdomain of HIV-1 reverse transcriptase affects sensitivity to NNRTIs and RNaseH activity.
    Wright DW; Deuzing IP; Flandre P; van den Eede P; Govaert M; Setiawan L; Coveney PV; Marcelin AG; Calvez V; Boucher CA; Beerens N
    PLoS One; 2013; 8(10):e74078. PubMed ID: 24098331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploiting drug-resistant enzymes as tools to identify thienopyrimidinone inhibitors of human immunodeficiency virus reverse transcriptase-associated ribonuclease H.
    Masaoka T; Chung S; Caboni P; Rausch JW; Wilson JA; Taskent-Sezgin H; Beutler JA; Tocco G; Le Grice SF
    J Med Chem; 2013 Jul; 56(13):5436-45. PubMed ID: 23631411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of HIV-1 and avian myeloblastosis virus reverse transcriptase fidelity on RNA and DNA templates.
    Yu H; Goodman MF
    J Biol Chem; 1992 May; 267(15):10888-96. PubMed ID: 1375233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced dNTP interaction of human immunodeficiency virus type 1 reverse transcriptase promotes strand transfer.
    Operario DJ; Balakrishnan M; Bambara RA; Kim B
    J Biol Chem; 2006 Oct; 281(43):32113-21. PubMed ID: 16926150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition mechanisms of HIV-1, Mo-MuLV and AMV reverse transcriptases by Kelletinin A from Buccinulum corneum.
    Orlando P; Strazzullo G; Carretta F; De Falco M; Grippo P
    Experientia; 1996 Aug; 52(8):812-7. PubMed ID: 8774754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions between HIV-1 reverse transcriptase and the downstream template strand in stable complexes with primer-template.
    Rutvisuttinunt W; Meyer PR; Scott WA
    PLoS One; 2008; 3(10):e3561. PubMed ID: 18974785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for dNTP binding of human immunodeficiency virus type 1 reverse transcriptase in viral mutagenesis.
    Weiss KK; Chen R; Skasko M; Reynolds HM; Lee K; Bambara RA; Mansky LM; Kim B
    Biochemistry; 2004 Apr; 43(15):4490-500. PubMed ID: 15078095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on the effects of truncating alpha-helix E' of p66 human immunodeficiency virus type 1 reverse transcriptase on template-primer binding and fidelity of DNA synthesis.
    Menéndez-Arias L
    Biochemistry; 1998 Nov; 37(47):16636-44. PubMed ID: 9843431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-mediated inhibition of HIV-1 reverse transcriptase polymerase activity. Interaction with a possible deoxynucleoside triphosphate binding domain.
    Wu J; Amandoron E; Li X; Wainberg MA; Parniak MA
    J Biol Chem; 1993 May; 268(14):9980-5. PubMed ID: 7683687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alternative divalent cations (Zn²⁺, Co²⁺, and Mn²⁺) are not mutagenic at conditions optimal for HIV-1 reverse transcriptase activity.
    Achuthan V; DeStefano JJ
    BMC Biochem; 2015 May; 16():12. PubMed ID: 25934642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p66/p51 and p51/p51 recombinant forms of reverse transcriptase from human immunodeficiency virus type 1--interactions with primer tRNA(Lys3), initiation of cDNA synthesis, and effect of inhibitors.
    Dufour E; El Dirani-Diab R; Boulmé F; Fournier M; Nevinsky G; Tarrago-Litvak L; Litvak S; Andreola ML
    Eur J Biochem; 1998 Jan; 251(1-2):487-95. PubMed ID: 9492322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structures of an N-terminal fragment from Moloney murine leukemia virus reverse transcriptase complexed with nucleic acid: functional implications for template-primer binding to the fingers domain.
    Najmudin S; Coté ML; Sun D; Yohannan S; Montano SP; Gu J; Georgiadis MM
    J Mol Biol; 2000 Feb; 296(2):613-32. PubMed ID: 10669612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of allosteric inhibition of HIV-1 reverse transcriptase revealed by single-molecule and ensemble fluorescence.
    Schauer GD; Huber KD; Leuba SH; Sluis-Cremer N
    Nucleic Acids Res; 2014 Oct; 42(18):11687-96. PubMed ID: 25232099
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymerization and RNase H activities of the reverse transcriptases from avian myeloblastosis, human immunodeficiency, and Moloney murine leukemia viruses are functionally uncoupled.
    DeStefano JJ; Buiser RG; Mallaber LM; Myers TW; Bambara RA; Fay PJ
    J Biol Chem; 1991 Apr; 266(12):7423-31. PubMed ID: 1708386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of a covalently trapped catalytic complex of HIV-1 reverse transcriptase: implications for drug resistance.
    Huang H; Chopra R; Verdine GL; Harrison SC
    Science; 1998 Nov; 282(5394):1669-75. PubMed ID: 9831551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of steric hindrance in 3TC resistance of human immunodeficiency virus type-1 reverse transcriptase.
    Gao HQ; Boyer PL; Sarafianos SG; Arnold E; Hughes SH
    J Mol Biol; 2000 Jul; 300(2):403-18. PubMed ID: 10873473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.